Steminent Biotherapeutics Inc. (TPEX:7729)
81.50
-2.00 (-2.40%)
Mar 24, 2026, 1:52 PM CST
229.29% (1Y)
| Market Cap | 5.56B +336.4% |
| Revenue (ttm) | n/a |
| Net Income | -156.75M |
| EPS | -2.79 |
| Shares Out | 66.63M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 273,541 |
| Average Volume | 559,393 |
| Open | 84.00 |
| Previous Close | 83.50 |
| Day's Range | 81.10 - 85.20 |
| 52-Week Range | 15.25 - 95.60 |
| Beta | 0.41 |
| RSI | 48.56 |
| Earnings Date | Apr 22, 2026 |